“Omicron” Hospitalization Rate Is Just 20% of Prior Variants, Study From South Africa Finds

Just 38% of prior variants according to UK data

A pre-print study from South Africa, published on Tuesday, has found that the risk of being hospitalised with Omicron is just a fifth of the risk with Delta. The study looked at all probable Omicron infections in the country between October 1st and December 6th, and took into account factors associated with hospitalisation such as vaccination status and age. It found that the adjusted risk of being admitted to hospital with probable Omicron infection (defined as S-gene dropout, SGTF) compared to non-Omicron infection is just 0.2, i.e., a fifth of the risk, or an 80% reduction.

Here are the results as stated in the abstract:

From October 1st through December 6th 2021, 161,328 COVID-19 cases were reported nationally; 38,282 were tested using TaqPath PCR and 29,721 SGTF infections were identified. The proportion of SGTF infections increased from 3% in early October (week 39) to 98% in early December (week 48). On multivariable analysis, after controlling for factors associated with hospitalisation, individuals with SGTF infection had lower odds of being admitted to hospital compared to non-SGTF infections (adjusted odds ratio (aOR) 0.2, 95% confidence interval (CI) 0.1-0.3). Among hospitalised individuals, after controlling for factors associated with severe disease, the odds of severe disease did not differ between SGTF-infected individuals compared to non-SGTF individuals diagnosed during the same time period (aOR 0.7, 95% CI 0.3-1.4). Compared to earlier Delta infections, after controlling for factors associated with severe disease, SGTF-infected individuals had a lower odds of severe disease (aOR 0.3, 95% CI 0.2-0.6).

The researchers say the reduction in severity is likely in part to be a result of high population immunity, a factor which would also apply to the U.K after several waves of Covid.

The study confirms the findings from Denmark of a 60% reduction in hospitalisation risk.

Meanwhile, reported infections in Gauteng province continue to decline.

Nonetheless, SAGE continues to make the case for restrictions – and Boris continues to listen.

Read the full study here.

Source: The Daily Sceptic

Analysis of data from England by the UKHSA released today confirms that the Omicron variant is causing less severe illness than Delta. The new Technical Briefing, number 33, finds that risk of emergency admission to hospital with Omicron compared to Delta was reduced by 62%, confirming earlier results from South AfricaDenmarkEdinburgh and Imperial.

Read the BBC story here.

The briefing also shows that the Omicron household secondary attack rate (the proportion of household contacts an infected person infects) has dropped to 13.1%, meaning nearly 87% of people who live with a person infected with Omicron do not go on to test positive. This compares to a current household secondary attack rate for Delta of 10.1%, so almost the same, differing by only 3%. Note that the direct secondary attack rate for Alpha this time last year was 15.5%, so the claim that Omicron is spreading much faster than previous variants – is much more transmissible – is not supported by this data.

Source: The Daily Sceptic

  1. Dale says

    How they find Omicron for the layperson: present runny nose + “must be Covid” + test negative for Covid = “well then, it must be Omicron.”

  2. ken says

    Once again,,, Sars Cov 2,,, its offspring Delta and Moronic do not exist…. as per ‘real’ science.

    You are being had, folks.

  3. ken says

    Notice not one chart of the deaths…. Can’t be accidental.

    Amazing,,, between under reported Vaers plus Medicare count of 46,000, for a total of 66,244 in only 11 months. . Approx 12,000 more than the US deaths in Viet Nam over 10 years. And all you hear from Americans is get the shot,,, it’s safe and effective. .

    Well here’s their safe and effective…

  4. Mr Reynard says

    Those bimbos pictured above, must be very popular with the people ??

Leave A Reply

Your email address will not be published.